EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark ENZO was filed as Word mark on 06/22/2007 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/13/2008.
The current status of the mark is "Registration expired".
| Trademark form | Word mark |
| File reference | 006028732 |
| Application date | June 22, 2007 |
| Publication date | November 12, 2007 |
| Entry date | May 13, 2008 |
| Expiration date | June 22, 2017 |
Trademark owner
527 Madison Avenue
10022 New York,
US
10022 New York,
US
Trademark representatives
Piazza Armando Diaz, 7
20123 Milano
IT
goods and services
1
A full line of biochemical reagents, such as antibodies, plasmids, enzymes, enzyme stabilizers, buffers, interferon, nucleotides and polynucleotides sold individually or in kit form for scientific and medical research use; microarrays for scientific and medical research use
5
A full line of biochemical reagents, such as antibodies, plasmids, enzymes, enzyme stabilizers, buffers, interferon, nucleotides and polynucleotides sold individually or in kit form for diagnostic/clinical use; a full line of biochemical reagents, such as antibodies, plasmids, enzymes, enzyme stabilizers, buffers, interferon, nucleotides and polynucleotides sold individually or in kit form for use in prognostics/theranostics; microarrays for diagnostic/clinical use and for use in prognostics/theranostics; a peptide for the treatment of uveitis; a gene therapy vector for the treatment of HIV infection; an indìvidualized medicine or treatment utilizing processed biological samples from an individual patient for the treatment of the symptoms of Crohn's disease in that patient; intermediary metabolites or compounds derived from intermediary metabolites, such as glucocerebrosides for the treatment of immune-mediated or immune-related diseases or disorders, infectious diseases, metabolic disorders, liver disorders and cancer, and for regulating and manipulating immune responses; compositions for the stimulation, enhancement, regulation or inhibition of bone formation, bone-remodeling, mineralization, and the self-renewal, proliferation and differentiation of cells; compositions for the treatment of bone disease, bone fracture, bone injury, bone abnormality, viral infections, tumors or growth, periodontal disease; compositions for inducing bone formation, cartilage formation, adipogenesis or myogenesis; compositions for modulating pathophysiological processes or any bone-related activity; compositions for the inhibition of Disheveled proteins; sclerostin for use in the inhibition of Wnt signaling and bone formation; educated NKT cells for use in the treatment of immune-related or immune mediated disorders or diseases; educated NKT cell populations for use in modulating TH1/TH2 cell balance toward anti-inflammatory or pro-inflammatory cytokine producing cells
9
Microarray readers for scientific and medical research use, diagnostic/clinical use and for use in prognostics/theranostics
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 24, 2018 | Extension, Trade mark expired | ||
| January 3, 2018 | Change Representative, Published | ||
| January 5, 2011 | Change Representative, Published |
ID: 11006028732